Related Experiment Video
Updated: Jan 5, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Medicines prescription patterns in European neonatal units
Inge Mesek1, Georgi Nellis2,3, Jana Lass4,5
1Department of Microbiology, University of Tartu, Tartu, Estonia. inge.mesek@ut.ee.
Insights
Drug use in European neonatal intensive care units varies by infant gestational age and geographic region. This highlights a need for standardized, evidence-based guidelines to improve neonatal care across Europe.
Area of Science:
- Neonatal pharmacology
- Pediatric drug utilization
Background:
- Hospitalized neonates are the highest drug-consuming age group.
- Existing drug consumption data is limited by patient characteristics and local practices.
- Large-scale international studies on neonatal drug use are lacking.
Purpose of the Study:
- To describe drug use patterns in European neonatal units.
- To analyze associations between drug prescription rates, gestational age, and geographic region.
Main Methods:
- A one-day point prevalence study conducted across 21 European countries (January-June 2012).
- Data collected via a web-based database, registering neonatal prescriptions and demographics.
- Logistic regression used to analyze the impact of gestational age and region on prescription rates.
Main Results:
- 2173 prescriptions for 726 neonates were analyzed.
- Top prescribed drugs included multivitamins, vitamin D, caffeine, and antibiotics.
- Gestational age significantly influenced the use of all common drug groups.
- Geographic region impacted the use of drugs in several key therapeutic areas.
Conclusions:
- Gestational age significantly impacts neonatal drug prescriptions.
- Regional variations in drug use (excluding anti-infectives) suggest a need for harmonized guidelines.
- Collaborative efforts are needed to develop evidence-based neonatal drug use guidelines.
Abstract:
Background Hospitalized neonates receive the highest number of drugs compared to all other age groups, but consumption rates vary between studies depending on patient characteristics and local practices. There are no large-scale international studies on drug use in neonatal units. Objective We aimed to describe drug use in European neonatal units and characterize its associations with geographic region and gestational age. Setting A one-day point prevalence study was performed as part of the European Study of Neonatal Exposure to Excipients from January to June 2012. Method All neonatal prescriptions and demographic data were registered in a web-based database. The impact of gestational age and region on prescription rate were analysed with logistic regression. Main outcome measure The number and variety of drugs prescribed to hospitalized neonates in different gestational age groups and geographic regions. Results In total, 21 European countries with 89 neonatal units participated. Altogether 2173 prescriptions given to 726 neonates were registered. The 10 drugs with the highest prescription rate were multivitamins, vitamin D, caffeine, gentamicin, amino acids for parenteral nutrition, phytomenadione, ampicillin, benzylpenicillin, fat emulsion for parenteral nutrition and probiotics. The six most commonly prescribed ATC groups (alimentary tract and metabolism, blood and blood-forming organs, systemic anti-infectives, nervous, respiratory and cardiovascular system) covered 98% of prescriptions. Gestational age significantly affected the use of all commonly used drug groups. Geographic region influenced the use of alimentary tract and metabolism, blood and blood-forming organs, systemic anti-infectives, nervous and respiratory system drugs. Conclusion While gestational age-dependent differences in neonatal drug use were expected, regional variations (except for systemic anti-infectives) indicate a need for cooperation in developing harmonized evidence-based guidelines and suggest priorities for collaborative work.
More Related Videos
11:50Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Affecting Drug Response: Overview